Jump to content
Science Forums

Neurogene Announces FDA Clearance of IND for NGN-401 Gene Therapy for Children with Rett Syndrome


Vmedvil

Recommended Posts

It seems neurogene announces FDA clearance of IND for NGN-401 gene therapy for children with Rett Sydrome, read more at https://www.businesswire.com/news/home/20230123005045/en/Neurogene-Announces-FDA-Clearance-of-IND-for-NGN-401-Gene-Therapy-for-Children-with-Rett-Syndrome

 

Do you think that gene therapies for Rett Sydrome are going to be effective in treatment of the sydrome?

Link to comment
Share on other sites

"A rare genetic mutation affecting brain development in girls.

Despite being caused by a gene mutation, Rett syndrome is rarely inherited.
Infants seem healthy during their first six months, but over time, rapidly lose coordination, speech, and use of the hands. Symptoms may then stabilize for years.
There's no cure, but medications, physical and speech therapy, and nutritional support help manage symptoms, prevent complications, and improve quality of life."
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...